IN BRIEF: Scancell names David Schilansky as interim finance chief
Scancell Holdings PLC - Oxford-based pharmaceutical company focused on cancer immunotherapies - Appoints ‘highly experienced senior healthcare executive and entrepreneur’ David Schilansky, effective immediately, as...
Thu, 02/04/2026 - 14:28